OPDP: Xarelto ad minimized risks

07/1/2013 | Medical Marketing & Media

An ad for Janssen's Xarelto blood thinner that appeared in WebMD Magazine was designed in such a way that risks were minimized and did not appear to be connected to efficacy claims, the FDA Office of Prescription Drug Promotion said in an untitled letter.

View Full Article in:

Medical Marketing & Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN